CAMBRIDGE, Mass., Oct. 9, 2025 /PRNewswire/ — Leap Therapeutics (Nasdaq:LPTX), a biotechnology company focapplyd on developing tarobtained and immuno-oncology therapeutics,…
Read More

CAMBRIDGE, Mass., Oct. 9, 2025 /PRNewswire/ — Leap Therapeutics (Nasdaq:LPTX), a biotechnology company focapplyd on developing tarobtained and immuno-oncology therapeutics,…
Read More